Benzoxazinoid Metabolites Regulate Innate Immunity against Aphids and Fungi in MaizeAHMAD, Shakoor; VEYRAT, Nathalie; TON, Jurriaan et al.Plant physiology (Bethesda). 2011, Vol 157, Num 1, pp 317-327, issn 0032-0889, 11 p.Article

High performance wood composites based on benzoxazine-epoxy alloysJUBSILP, Chanchira; TAKEICHI, Tsutomu; HIZIROGLU, Salim et al.Bioresource technology. 2008, Vol 99, Num 18, pp 8880-8886, issn 0960-8524, 7 p.Article

Estimation of heritability of benzoxazinoid production in rye (Secale cereale) using gas chromatographic analysisBROOKS, Ashley M; DANEHOWER, David A; MURPHY, J. Paul et al.Plant breeding. 2012, Vol 131, Num 1, pp 104-109, issn 0179-9541, 6 p.Article

Synthesis of 2-substituted 3,4-dihydro-2H-1,4-benzoxazines through ligandless copper-catalyzed cyclization of hydroxysulfonamides under phase-transfer catalysis conditionsALBANESE, D; LANDINI, D; LUPI, V et al.Journal of molecular catalysis. A, Chemical. 2008, Vol 288, Num 1-2, pp 28-32, issn 1381-1169, 5 p.Article

Compromising Mitochondrial Function with the Antiretroviral Drug Efavirenz Induces Cell Survival-Promoting AutophagyAPOSTOLOVA, Nadezda; GOMEZ-SUCERQUIA, Leysa J; GORTAT, Anna et al.Hepatology (Baltimore, Md.). 2011, Vol 54, Num 3, pp 1009-1019, issn 0270-9139, 11 p.Article

Interaction of Ginkgo biloba with efavirenzWIEGMAN, Dirk-Jan; BRINKMAN, Kees; FRANSSEN, Eric J. F et al.AIDS (London). 2009, Vol 23, Num 9, pp 1184-1185, issn 0269-9370, 2 p.Article

Promoting Effects of Urethane Derivatives of Phenols on the Ring-Opening Polymerization of 1,3-BenzoxazinesSUDO, Atsushi; MORI, Atsushi; ENDO, Takeshi et al.Journal of polymer science. Part A. Polymer chemistry. 2011, Vol 49, Num 10, pp 2183-2190, issn 0887-624X, 8 p.Article

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysisFORD, Nathan; CALMY, Alexandra; MOFENSON, Lynne et al.AIDS (London). 2011, Vol 25, Num 18, pp 2301-2304, issn 0269-9370, 4 p.Article

Clinical interaction between efavirenz and phenytoinSPAK, Cedric W; DHANIREDDY, Shireesha; KOSEL, Bradley W et al.AIDS (London). 2008, Vol 22, Num 1, pp 164-165, issn 0269-9370, 2 p.Article

Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class?FUX, Christoph A; BAUMANN, Sandra; FURRER, Hansjakob et al.AIDS (London). 2011, Vol 25, Num 6, pp 876-878, issn 0269-9370, 3 p.Article

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA studyVAN LUIN, Matthijs; BANNISTER, Wendy P; LUNDGREN, Jens D et al.Antiviral therapy (London). 2009, Vol 14, Num 1, pp 75-83, issn 1359-6535, 9 p.Article

Inhibition of Mitochondrial Function by Efavirenz Increases Lipid Content in Hepatic CellsBLAS-GARCIA, Ana; APOSTOLOVA, Nadezda; BALLESTEROS, Daniel et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 1, pp 115-125, issn 0270-9139, 11 p.Article

Efavirenz and bone healthFABBRICIANI, Gianluigi; DE SOCIO, Giuseppe Vittorio L.AIDS (London). 2009, Vol 23, Num 9, issn 0269-9370, p. 1181Article

Aromatic-ring-functionalised benzoxazinones in the system Oryza sativa-Echinochloa crus-galli as biorational herbicide modelsMACIAS, Francisco A; CHINCHILLA, Nuria; VARELA, Rosa M et al.Pest management science. 2009, Vol 65, Num 10, pp 1104-1113, issn 1526-498X, 10 p.Article

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)WOHL, David A; ORKIN, Chloe; DOROANA, Manuela et al.Antiviral therapy (London). 2014, Vol 19, Num 2, pp 191-200, issn 1359-6535, 10 p.Article

Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adultsCOHEN, Calvin; WOHL, David; WHITE, Kirsten et al.AIDS (London). 2014, Vol 28, Num 7, pp 989-997, issn 0269-9370, 9 p.Article

Changes in Fat Mitochondrial DNA and Function in Subjects Randomized to Abacavir-Lamivudine or Tenofovir DF―Emtricitabine With Atazanavir-Ritonavir or Efavirenz: AIDS Clinical Trials Group Study A5224s, Substudy of A5202MCCOMSEY, Grace A; DAAR, Eric S; GERSCHENSON, Mariana et al.The Journal of infectious diseases. 2013, Vol 207, Num 4, pp 604-611, issn 0022-1899, 8 p.Article

Amorphous-State Characterization of Efavirenz—Polymer Hot-Melt Extrusion Systems for Dissolution EnhancementKUMAR SATHIGARI, Sateesh; RADHAKRISHNAN, Vinod K; DAVIS, Virginia A et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 9, pp 3456-3464, issn 0022-3549, 9 p.Article

Associations Between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 Alleles in Relation to Efavirenz and Nevirapine Pharmacokinetics in HIV-Infected IndividualsHEIL, Sandra G; DER ENDE, Marchina E. Van; SCHENK, Paul W et al.Therapeutic drug monitoring. 2012, Vol 34, Num 2, pp 153-159, issn 0163-4356, 7 p.Article

Compartment-Specific Gene Regulation of the CAR Inducer Efavirenz In VivoMEYER ZU SCHWABEDISSEN, H. E; OSWALD, S; NAUCK, M et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 1, pp 103-111, issn 0009-9236, 9 p.Article

Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenzLETICEE, Nadia; VIARD, Jean-Paul; YAMGNANE, Amina et al.Contraception (Stoneham). 2012, Vol 85, Num 4, pp 425-427, issn 0010-7824, 3 p.Article

Discontinuation of Atripla as first-line therapy in HIV-1 infected individualsSCOURFIELD, Andrew; JIEXIN ZHENG; CHINTHAPALLI, Suchitra et al.AIDS (London). 2012, Vol 26, Num 11, pp 1399-1401, issn 0269-9370, 3 p.Article

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trialsNELSON, Mark; AMAYA, Gerardo; VANVEGGEL, Simon et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 8, pp 2020-2028, issn 0305-7453, 9 p.Article

Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageOUATTARA, Eric N; ANGLARET, Xavier; FREEDBERG, Kenneth A et al.AIDS (London). 2012, Vol 26, Num 5, pp 625-634, issn 0269-9370, 10 p.Article

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavirYOUNG, Jim; SCHÄFER, Juliane; BUCHER, Heiner C et al.AIDS (London). 2012, Vol 26, Num 5, pp 567-575, issn 0269-9370, 9 p.Article